Aktiesnakken — August 2010
-
Det er US patent ansøgningen vi snakker om...
-
Den har været igennem en eksaminator, og det ser lovende ud... Høiberg havde jo også sagt at
-
det var overkommeligt
-
Men vi er også meget lavt nede i kurs på genmab, fundamentalt set
-
!Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind